| Functional amyloids as natural storage of peptide hormones in pituitary secretory granules SK Maji, MH Perrin, MR Sawaya, S Jessberger, K Vadodaria, ... Science 325 (5938), 328-332, 2009 | 1117 | 2009 |
| Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report PT Nelson, DW Dickson, JQ Trojanowski, CR Jack, PA Boyle, K Arfanakis, ... Brain 142 (6), 1503-1527, 2019 | 1040 | 2019 |
| Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology RA Rissman, WW Poon, M Blurton-Jones, S Oddo, R Torp, MP Vitek, ... The Journal of clinical investigation 114 (1), 121-130, 2004 | 681 | 2004 |
| A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease RS Turner, RG Thomas, S Craft, CH Van Dyck, J Mintzer, BA Reynolds, ... Neurology 85 (16), 1383-1391, 2015 | 635 | 2015 |
| Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease C Moussa, M Hebron, X Huang, J Ahn, RA Rissman, PS Aisen, RS Turner Journal of neuroinflammation 14, 1-10, 2017 | 575 | 2017 |
| Brain cell type–specific enhancer–promoter interactome maps and disease-risk association A Nott, IR Holtman, NG Coufal, JCM Schlachetzki, M Yu, R Hu, CZ Han, ... Science 366 (6469), 1134-1139, 2019 | 524 | 2019 |
| The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ... Alzheimer's & Dementia 7 (4), 386-395. e6, 2011 | 425 | 2011 |
| Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin‐containing projections with targets bearing type 2 CRF receptors JC Bittencourt, J Vaughan, C Arias, RA Rissman, WW Vale, ... Journal of Comparative Neurology 415 (3), 285-312, 1999 | 405 | 1999 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 397 | 2013 |
| Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need GM Babulal, YT Quiroz, BC Albensi, E Arenaza-Urquijo, AJ Astell, ... Alzheimer's & Dementia 15 (2), 292-312, 2019 | 373 | 2019 |
| Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile CN Winston, EJ Goetzl, JC Akers, BS Carter, EM Rockenstein, D Galasko, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 3, 63-72, 2016 | 347 | 2016 |
| Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain TT Rohn, RA Rissman, MC Davis, YE Kim, CW Cotman, E Head Neurobiology of disease 11 (2), 341-354, 2002 | 309 | 2002 |
| The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease JY Hur, GR Frost, X Wu, C Crump, SJ Pan, E Wong, M Barros, T Li, P Nie, ... Nature 586 (7831), 735-740, 2020 | 263 | 2020 |
| Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic SE O'Bryant, MM Mielke, RA Rissman, S Lista, H Vanderstichele, ... Alzheimer's & Dementia 13 (1), 45-58, 2017 | 263 | 2017 |
| Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial S Craft, R Raman, TW Chow, MS Rafii, CK Sun, RA Rissman, ... JAMA neurology 77 (9), 1099-1109, 2020 | 248 | 2020 |
| The role of caspase cleavage of tau in Alzheimer disease neuropathology CW Cotman, WW Poon, RA Rissman, M Blurton-Jones Journal of neuropathology & experimental neurology 64 (2), 104-112, 2005 | 242 | 2005 |
| Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research SE O'Bryant, V Gupta, K Henriksen, M Edwards, A Jeromin, S Lista, ... Alzheimer's & Dementia 11 (5), 549-560, 2015 | 241 | 2015 |
| GABAA receptors in aging and Alzheimer’s disease RA Rissman, AL De Blas, DM Armstrong Journal of neurochemistry 103 (4), 1285-1292, 2007 | 231 | 2007 |
| GABAA receptors in aging and Alzheimer’s disease RA Rissman, AL De Blas, DM Armstrong Journal of neurochemistry 103 (4), 1285-1292, 2007 | 231 | 2007 |
| Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer’s disease RA Rissman, WC Mobley Journal of neurochemistry 117 (4), 613-622, 2011 | 215 | 2011 |
